---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017185"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T12:44:00.835104+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Processa amends Yuhan license; annual meeting adjourned for lack of quorum

## Summary
- Amendment No. 1 to License Agreement with Yuhan Corporation effective June 11, 2025, linked to term sheet with Intact Therapeutics dated June 17, 2025.
- Annual meeting on June 30, 2025 adjourned due to insufficient quorum; reconvened for July 30, 2025 at 1:00 PM in Hanover, MD.
- Record date remains May 1, 2025; previously submitted proxies and votes remain valid without further action.
- No financial or operational details of the Yuhan amendment or Intact Therapeutics term sheet were disclosed in the filing.

## SEC filing metadata
- accession: 0001641172-25-017185
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 1.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000164117225017185/0001641172-25-017185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000164117225017185/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017185
- JSON: https://secwatch.observer/filing/0001641172-25-017185.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.